Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Australia's Cochlear Plans $39 Million Manufacturing Facility in Chengdu

publication date: Jul 13, 2017
Cochlear, an Australian medical device company that makes cochlear implants to treat hearing loss, announced plans to build a $38.6 million manufacturing facility in Chengdu, China. Cochlear said it needs to expand before it reaches capacity constraints in its Australian facilities. The company declared the China facility would save only a small amount in manufacturing costs, although Cochlear's hearing products were not granted China tenders this year, presumably because of price. The tenders were split between Austria's Med-El at $5490 per device and China's own Nurotron, located in Hangzhou, at $5916. More details....

Stock Symbol: (ASE: COH)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital